Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Net Income Growth Recovery in ProgressRecovering
Percentile Rank25
Studio
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P25
Within normal range
vs 3Y Ago
-2.6x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-41.93%
2024-285.99%
2023193.68%
202216.37%
20210.00%